Comments
Ahmedabad, Oct 21 Torrent Pharmaceuticals Ltd on Friday posted consolidated net profit of ₹312 crore for the second quarter ended September 30, 2022 marginally down by 1 per cent against ₹316 crore in the corresponding quarter a year ago.
The company’s consolidated revenues from operations increased 7 per cent to ₹2,291 crore for the quarter (₹2,137 crore). Consolidated expenses increased by 7 per cent to ₹1,844 crore from ₹1,716 crore in the corresponding quarter a year ago.
On standalone basis, company’s net profit for the quarter fell by 17 per cent to ₹272 crore (₹326 crore). Revenues from operations stood at ₹1,928 crore, up 7 per cent from ₹1,799 crore in the same quarter last year.
The company’s India revenues grew by 13 per cent to ₹1,224 crore for the quarter. From the international markets, revenues from Brazil market stood at ₹185 crore, up by 19 per cent, US revenues grew 3 per cent to ₹292 crore. The revenues from Germany fell by 12 per cent to ₹220 crore.
The company reported gross EBITDA margins of 30 per cent for the quarter and EBITDA stood at ₹694 crore, down by 2 per cent over same period last year.
Torrent Pharmaceuticals shares ended negative at ₹1,578 on Friday, down by nearly 1 per cent from previous close on BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.